A rapid and sensitive assay for detection of replication-competent adenoviruses by a combination of microcarrier cell culture and quantitative PCR

Journal of Virological Methods

Volumn 145, Issue 2, 2007, Pages 89-95

  Schalk, Johanna A C ^a   de Vries, Claudette G J C A ^a   Orzechowski, Tom J H ^a   Rots, Marianne G ^b  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Adenoviral vector; Infectivity PCR; Microcarriers; Quantitative PCR; Replication competent adenovirus; Safety

Indexed keywords

ADENOVIRUS VECTOR;

ADENOVIRUS; ARTICLE; CONTROLLED STUDY; DNA ISOLATION; HUMAN; HUMAN CELL; INCUBATION TIME; MICROCARRIER CULTURE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS DETECTION; VIRUS INFECTION; VIRUS REPLICATION;

ADENOVIRUSES, HUMAN; CELL CULTURE TECHNIQUES; CELL LINE; GENETIC VECTORS; HUMANS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VIRUS CULTIVATION;

ADENOVIRIDAE;

EID: 34548206748     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2007.05.010     Document Type: Article

References (32)

1. Alemany R., and Curiel D.T. CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors. Gene Ther. 8 (2001) 1347-1353
2. Anderson R.D., Haskell R.E., Xia H., Roessler B.J., and Davidson B.L. A simple method for the rapid generation of recombinant adenovirus vectors. Gene Ther. 7 (2000) 1034-1038
3. Dion L.D., Fang J., and Garver Jr. R.I. Supernatant rescue assay vs. polymerase chain reaction for detection of wild type adenovirus-contaminating recombinant adenovirus stocks. J. Virol. Methods 56 (1996) 99-107
4. Fallaux F.J., Bout A., van der Velde I., van den Wollenberg D.J.M., Hehir K.M., Keegan J., Auger C., Cramer S.J., van Ormondt H., van der Eb A.J., Valerio D., and Hoeben R.C. New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Hum. Gene Ther. 9 (1998) 1909-1917
5. Gao G.-P., Yang Y., and Wilson J.M. Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy. J. Virol. 70 (1996) 8934-8943
6. Gao G.-P., Engdahl R.K., and Wilson J.M. A cell line for high-yield production of E1-deleted adenovirus vectors without the emergence of replication-competent virus. Hum. Gene Ther. 11 (2000) 213-219
7. Graham F.L., Smiley J., Russel W.C., and Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36 (1977) 59-74
8. Hehir K.M., Armentano D., Cardoz L.M., Choquette T.L., Berthlette P.B., White G.A., Couture L.A., Everton M.B., Keegan J., Martin J.M., Pratt D.A., Smith M.P., Smith A.E., and Wadsworth S.C. Molecular characterization of replication-competent variants of adenovirus vectors and genome modifications to prevent their occurrence. J. Virol. 70 (1996) 8459-8467
9. Hermens W.T., and Verhaagen J. Adenoviral vector-mediated gene expression in the nervous system of immunocompetent Wistar and T cell-deficient nude rats: preferential survival of transduced astroglial cells in nude rats. Hum. Gene Ther. 8 (1997) 1049-1063
10. Hutchins B. Development of a reference material for characterizing adenovirus vectors. Bioprocess. J. 1 (2002) 25-28
11. Imler J.-L., Bout A., Dreyer D., Dieterle A., Schultz H., Valerio D., Mehtali M., and Pavirani A. Trans-complementation of E1-deleted adenovirus: a new vector to reduce the possibility of codissemination of wild-type and recombinant adenoviruses. Hum. Gene Ther. 6 (1995) 711-721
12. Imler J.-L., Chartier C., Dryer D., Dieterle A., Sainte-Marie M., Faure T., Pavirani A., and Mehtali M. Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectors. Gene Ther. 3 (1996) 75-84
13. Ishii-Watabe A., Uchida E., Iwata A., Nagata R., Satoh K., Fan K., Murata M., Mizuguchi H., Kawasaki N., Kawanishi T., Yamaguchi T., and Hayakawa T. Detection of replication-competent adenoviruses spiked into recombinant adenovirus vector products by infectivity PCR. Mol. Ther. 8 (2003) 1009-1016
14. Ko G., Cromeans T.L., and Sobsey M.D. Detection of infectious adenovirus in cell culture by mRNA reverse transcription-PCR. Appl. Environ. Microbiol. 69 (2003) 7377-7384
15. Ko G., Jothikumar N., Hill V.R., and Sobsey M.D. Rapid detection of infectious adenoviruses by mRNA real-time RT-PCR. J. Virol. Methods 127 (2005) 148-153
16. Lochmüller H., Jani A., Huard J., Prescott S., Simoneau M., Massie B., Karpati G., and Acsadi G. Emergence of early region 1-containing replication-competent adenovirus in stocks of replication-defective adenovirus recombinants (ΔE1 + ΔE3) during multiple passages in 293 cells. Hum. Gene Ther. 5 (1994) 1485-1491
17. Maizel J.V., White D.O., and Scharff M.D. The polypeptides of adenovirus. Virology 36 (1968) 115-125
18. Marzio G., Kerkvliet E., Bogaards J.A., Koelewijn S., de Groot A., Gijsbers L., Weverling G.J., Vogels R., Havenga M., Custers J., Pau M.G., Guichoux J.Y., Lewis J., and Goudsmit J. A replication-competent adenovirus assay for E1-deleted Ad35 vectors produced in PER.C6 cells. Vaccine 25 (2007) 2228-2237
19. Murakami P., Pungor E., Files J., Do L., van Rijnsoever R., Vogels R., Bout A., and McCaman M. A single short stretch of homology between adenoviral vector and packaging cell line can give rise to cytopathic effect-inducing, helper-dependent E1-positive particles. Hum. Gene Ther. 13 (2002) 909-920
20. Murakami P., Havenga M., Fawaz F., Vogels R., Marzio G., Pungor E., Files J., Do L., Goudsmit J., and McCaman M. Common structure of rare replication-deficient E1-positive particles in adenoviral vector batches. J. Virol. 78 (2004) 6200-6208
21. Pietersen A.M., van der Eb M.M., Rademaker H.J., van den Wollenberg D.J.M., Rabelink M.J.W.E., Kuppen P.J.K., van Dierendonck J.H., van Ormondt H., Masman D., van de Velde C.J.H., van der Eb A.J., Hoeben R.C., and Noteborn M.H.M. Specific tumor-cell killing with adenovirus vectors containing the apoptin gene. Gene Ther. 6 (1999) 882-892
22. Puntel M., Curtin J.F., Zirger J.M., Muhammad A.K.M., Xiong W., Liu C., Hu J., Kroeger K.M., Czer P., Sciascia S., Mondkar S., Lowenstein P.R., and Castro M.G. Quantification of high-capacity helper-dependent adenoviral vector genomes in vitro and in vivo, using quantitative TaqMan real-time polymerase chain reaction. Hum. Gene Ther. 17 (2006) 531-544
23. Rots M.G., Curiel D.T., Gerritsen W.R., and Haisma H.J. Targeted cancer gene therapy: the flexibility of adenoviral gene therapy vectors. J. Control. Release 87 (2003) 159-165
24. Rots M.G., Elferink M.G.L., Gommans W.M., Oosterhuis D., Schalk J.A.C., Curiel D.T., Olinga P., Haisma H.J., and Groothuis G.M.M. An ex vivo human model system to evaluate specificity of replicating and non-replicating gene therapy agents. J. Gene Med. 8 (2006) 35-41
25. Schaak J., Guo X., and Langer S.J. Characterization of a replication-incompetent adenovirus type 5 mutant deleted for the preterminal protein gene. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 14686-14691
26. Schagen F.H.E., Rademaker H.J., Rabelink M.J.W.E., van Ormondt H., Fallaux F.J., van der Eb A.J., and Hoeben R.C. Ammonium sulphate precipitation of recombinant adenovirus from culture medium: an easy method to increase the total virus yield. Gene Ther. 7 (2000) 1570-1574
27. Schalk J.A.C., van den Elzen C., Ovelgönne H., Baas C., and Jongen P.M.J.M. Estimation of the number of infectious measles viruses in live virus vaccines using quantitative real-time PCR. J. Virol. Methods 117 (2004) 179-187
28. Schalk J.A.C., de Vries C.G.J.C.A., and Jongen P.M.J.M. Potency estimation of measles, mumps and rubella trivalent vaccines with quantitative PCR infectivity assay. Biologicals 33 (2005) 71-79
29. Wang F., Puddy A.C., Mathis B.C., Montalvo A.G., Louis A.A., McMackin J.L., Xu J., Zhang Y., Tan C.Y., Schofield T.L., Wolf J.J., and Lewis J.A. Using QPCR to assign infectious potencies to adenovirus-based vaccines and vectors for gene therapy: toward a universal method for the facile quantitation of virus and vector potency. Vaccine 23 (2005) 4500-4508
30. Zhang W.W., Koch P.E., and Roth J.A. Detection of wild-type contamination in a recombinant adenoviral preparation by PCR. Biotechniques 18 (1995) 444-447
31. Zhou H., O'Neal W., Morral N., and Beaudet A.L. Development of a complementing cell line and a system for construction of adenovirus vectors with e1 and E2a deleted. J. Virol. 70 (1996) 7030-7038
32. Zhu J., Grace M., Casale J., Chang A.T.-I., Musco M.L., Bordens R., Greenberg R., Schaefer E., and Indelicato S.R. Characterization of replication-competent adenovirus isolates from large scale production of a recombinant adenoviral vector. Hum. Gene Ther. 10 (1999) 113-121